1. An overview on the chemistry, pharmacology and anticancer properties of tetrandrine and fangchinoline (alkaloids) from Stephania tetrandra roots
    Eric Wei Chiang Chan et al, 2021, Journal of Integrative Medicine CrossRef
  2. Toward Precision Medicine
    Carmen Elena Condrat et al, 2022, Genomic and Epigenomic Biomarkers of Toxicology and Disease CrossRef
  3. Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer
    Jia-shu Chen et al, 2023, Bioorganic Chemistry CrossRef
  4. Galangin suppresses human osteosarcoma cells: An exploration of its underlying mechanism
    Zhifan Yang et al, 2017, Oncology Reports CrossRef
  5. Alkaloids Exhibit a Meaningful Function as Anticancer Agents by Restraining Cellular Signaling Pathways
    Chong Guo et al, 2022, Mini-Reviews in Medicinal Chemistry CrossRef
  6. Fangchinoline suppresses growth and metastasis of melanoma cells by inhibiting the phosphorylation of FAK
    Jie Shi et al, 2017, Oncology Reports CrossRef
  7. Fangchinoline suppresses the growth and invasion of human glioblastoma cells by inhibiting the kinase activity of Akt and Akt-mediated signaling cascades
    Bingyu Guo et al, 2016, Tumor Biology CrossRef
  8. Study on spectrum-effect correlation for screening the effective components in Fangji Huangqi Tang basing on ultra-high performance liquid chromatography-mass spectrometry
    Xiao Liu et al, 2018, Phytomedicine CrossRef
  9. 5-Hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone, a polymethoxyflavone, exerts antitumor effect on PI3K/Akt signaling pathway in human gastric cancer cell BGC-7901
    Xinjian Wang et al, 2016, Journal of Receptors and Signal Transduction CrossRef
  10. Challenges and future directions of potential natural products leads against 2019-nCoV outbreak
    Meirambek Ospanov et al, 2020, Current Plant Biology CrossRef
  11. Network Pharmacology and Molecular Docking Integrated Strategy to the Screening of Active Components and Mechanisms of Stephaniae Tetrandrae Radix on Breast Cancer
    Kaiyue Wang et al, 2022, Processes CrossRef
  12. Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment
    Tijana Stanković et al, 2019, Current Medicinal Chemistry CrossRef
  13. Betulinic acid induces apoptosis by regulating PI3K/Akt signaling and mitochondrial pathways in human cervical cancer cells
    Tao Xu et al, 2017, International Journal of Molecular Medicine CrossRef
  14. New Potential Pharmacological Functions of Chinese Herbal Medicines via Regulation of Autophagy
    Betty Law et al, 2016, Molecules CrossRef
  15. Expression of heterologous oxalate decarboxylase in HEK293 cells confers protection against oxalate induced oxidative stress as a therapeutic approach for calcium oxalate stone disease
    Abhishek Albert et al, 2017, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
  16. Identification of Fangchinoline as a novel autophagy inhibitor with an adjuvant of chemotherapy against lung cancer
    Zhenyang Ren et al, 2023, Toxicology and Applied Pharmacology CrossRef
  17. N-methylsansalvamide elicits antitumor effects in colon cancer cells in vitro and in vivo by regulating proliferation, apoptosis, and metastatic capacity
    Juhee Park et al, 2023, Frontiers in Pharmacology CrossRef
  18. The Therapeutic Effects of Bioactive Compounds on Colorectal Cancer via PI3K/Akt/mTOR Signaling Pathway: A Critical Review
    Kübra Demir et al, 2024, Food Science & Nutrition CrossRef
  19. Fangchinoline Inhibited Proliferation of Neoplastic B-lymphoid Cells and Alleviated Sjögren’s Syndrome-like Responses in NOD/Ltj Mice via the Akt/mTOR Pathway
    Yanxiong Shao et al, 2022, Current Molecular Pharmacology CrossRef
  20. Fangchinoline suppresses the proliferation, invasion and tumorigenesis of human osteosarcoma cells through the inhibition of PI3K and downstream signaling pathways
    Xiucheng Li et al, 2017, International Journal of Molecular Medicine CrossRef
  21. Fangchinoline exerts anticancer effects on colorectal cancer by inducing autophagy via regulation AMPK/mTOR/ULK1 pathway
    Xiaocong Xiang et al, 2021, Biochemical Pharmacology CrossRef